Royal Bank of Canada
RUBY

Royal Bank of Canada’s Rubius Therapeutics, Inc RUBY Stock Holding History

Royal Bank of Canada’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3
Closed – – 7777
2022
Q4 		$0 Sell
3
-456
-99% -$125 ﹤0.01% 8060
2022
Q3 		$0 Buy
+459
New +$344 ﹤0.01% 8143
2022
Q2 		– Sell
-2,822
Closed -$16K – 8033
2022
Q1 		$16K Sell
2,822
-563
-17% -$3.58K ﹤0.01% 6741
2021
Q4 		$33K Buy
+3,385
New +$46.9K ﹤0.01% 6594
2021
Q3 		– Sell
-3,087
Closed -$75K – 8019
2021
Q2 		$75K Sell
3,087
-29
-0.9% -$725 ﹤0.01% 5771
2021
Q1 		$83K Sell
3,116
-18,420
-86% -$269K ﹤0.01% 5585
2020
Q4 		$164K Buy
+21,536
New +$128K ﹤0.01% 5002
2020
Q3 		– Sell
-700
Closed -$4K – 7082
2020
Q2 		$4K Sell
700
-121
-15% -$714 ﹤0.01% 6133
2020
Q1 		$4K Sell
821
-2,609
-76% -$19.4K ﹤0.01% 6139
2019
Q4 		$33K Buy
3,430
+2,875
+518% +$27.8K ﹤0.01% 5648
2019
Q3 		$4K Buy
+555
New +$6.47K ﹤0.01% 6141
2019
Q1 		– Sell
-150
Closed -$2K – 7219
2018
Q4 		$2K Sell
150
-291
-66% -$5.31K ﹤0.01% 6497
2018
Q3 		$11K Buy
+441
New +$10.1K ﹤0.01% 5958

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Royal Bank of Canada's RUBY Position: Q1 2023 in Review

Royal Bank of Canada sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 3 shares.

Royal Bank of Canada first reported a position in RUBY in Q3 2018 and held it in 13 quarters. The position peaked at $164K in Q4 2020. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • Royal Bank of Canada reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 3 Rubius Therapeutics, Inc shares in Q1 2023.
  • Royal Bank of Canada first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 13 quarters.
  • Royal Bank of Canada's Rubius Therapeutics, Inc position peaked at $164K in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.